Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration

Chenyin Wang1, Chun Yin Lau1, Fuqiang Ma1

  • 1School of Biological Sciences, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Insights

Gut bacteria influence neurodegenerative diseases. Researchers identified bacterial curli protein as a key factor promoting neuronal death in Parkinson's disease and other neurodegenerative conditions.

Area of Science:

  • Microbiology
  • Neuroscience
  • Genetics

Background:

  • Gut microbiota are increasingly linked to neurodegenerative disease progression.
  • The precise molecular mechanisms of microbe-host interactions in neurodegeneration remain largely unknown.

Purpose of the Study:

  • To identify bacterial genes influencing neurodegeneration using a genome-wide screen in *Caenorhabditis elegans*.
  • To elucidate the role of specific bacterial components, particularly curli, in promoting neurodegeneration.

Main Methods:

  • Conducted a genome-wide screen in *C. elegans* expressing human alpha-synuclein, feeding them *Escherichia coli* knockout mutants.
  • Focused on the curli amyloid fibril, genetically deleting or pharmacologically inhibiting its major subunit, CsgA.
  • Investigated curli's effect in *C. elegans* models of Alzheimer's, ALS, Huntington's disease, and human neuroblastoma cells.

Main Results:

  • Identified 38 bacterial genes involved in pathways like curli formation, LPS assembly, and adenosylcobalamin synthesis that promote neurodegeneration.
  • Deleting or inhibiting *E. coli*'s CsgA significantly reduced alpha-synuclein-induced neuronal death and improved neuronal function.
  • Bacterial curli colocalized with alpha-synuclein within neurons, promoting aggregation via cross-seeding and exacerbating neurodegeneration across multiple disease models.

Conclusions:

  • Bacterial curli amyloid fibrils are a critical factor driving neurodegeneration in Parkinson's disease and other neurological disorders.
  • Targeting curli formation presents a potential therapeutic strategy for mitigating neurodegenerative diseases linked to gut microbiota dysbiosis.